300 related articles for article (PubMed ID: 27238605)
1. Drug target identification in protozoan parasites.
Müller J; Hemphill A
Expert Opin Drug Discov; 2016 Aug; 11(8):815-24. PubMed ID: 27238605
[TBL] [Abstract][Full Text] [Related]
2. New approaches for the identification of drug targets in protozoan parasites.
Müller J; Hemphill A
Int Rev Cell Mol Biol; 2013; 301():359-401. PubMed ID: 23317822
[TBL] [Abstract][Full Text] [Related]
3. Selection of targets for drug development against protozoan parasites.
de Azevedo WF; Soares MB
Curr Drug Targets; 2009 Mar; 10(3):193-201. PubMed ID: 19275556
[TBL] [Abstract][Full Text] [Related]
4. Drug target identification in intracellular and extracellular protozoan parasites.
Müller J; Hemphill A
Curr Top Med Chem; 2011; 11(16):2029-38. PubMed ID: 21619514
[TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
6. The proteasome as a target for protozoan parasites.
Xie SC; Dick LR; Gould A; Brand S; Tilley L
Expert Opin Ther Targets; 2019 Nov; 23(11):903-914. PubMed ID: 31679410
[No Abstract] [Full Text] [Related]
7. Reporter genes facilitating discovery of drugs targeting protozoan parasites.
Dube A; Gupta R; Singh N
Trends Parasitol; 2009 Sep; 25(9):432-9. PubMed ID: 19720564
[TBL] [Abstract][Full Text] [Related]
8. Apicomplexan plastids as drug targets.
McFadden GI; Roos DS
Trends Microbiol; 1999 Aug; 7(8):328-33. PubMed ID: 10431206
[TBL] [Abstract][Full Text] [Related]
9. Antiprotozoan lead discovery by aligning dry and wet screening: prediction, synthesis, and biological assay of novel quinoxalinones.
Martins Alho MA; Marrero-Ponce Y; Barigye SJ; Meneses-Marcel A; Machado Tugores Y; Montero-Torres A; Gómez-Barrio A; Nogal JJ; García-Sánchez RN; Vega MC; Rolón M; Martínez-Fernández AR; Escario JA; Pérez-Giménez F; Garcia-Domenech R; Rivera N; Mondragón R; Mondragón M; Ibarra-Velarde F; Lopez-Arencibia A; Martín-Navarro C; Lorenzo-Morales J; Cabrera-Serra MG; Piñero J; Tytgat J; Chicharro R; Arán VJ
Bioorg Med Chem; 2014 Mar; 22(5):1568-85. PubMed ID: 24513185
[TBL] [Abstract][Full Text] [Related]
10. The apicoplast as a potential therapeutic target in and other apicomplexan parasites.
Soldati D
Parasitol Today; 1999 Jan; 15(1):5-7. PubMed ID: 10234168
[No Abstract] [Full Text] [Related]
11. Genomic databases and the search of protein targets for protozoan parasites.
Timmers LF; Pauli I; Barcellos GB; Rocha KB; Caceres RA; de Azevedo WF; Soares MB
Curr Drug Targets; 2009 Mar; 10(3):240-5. PubMed ID: 19275560
[TBL] [Abstract][Full Text] [Related]
12. Scientific hypothesis: a new strategy for the design of anti-protozoal drugs--DNA polymerase as a drug target.
Biñas M; Johnson AM
Appl Parasitol; 1994 Sep; 35(3):157-68. PubMed ID: 7951392
[TBL] [Abstract][Full Text] [Related]
13. Approaches for development of new antiprotozoan drugs.
Soares MB
Curr Drug Targets; 2009 Mar; 10(3):176-7. PubMed ID: 19275554
[No Abstract] [Full Text] [Related]
14. New mechanisms of drug resistance in parasitic protozoa.
Borst P; Ouellette M
Annu Rev Microbiol; 1995; 49():427-60. PubMed ID: 8561467
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Inhibitors as Antiparasitic Drugs: Pharmacological, Biochemical and Molecular Perspectives.
Mukherjee S; Mukherjee N; Gayen P; Roy P; Babu SP
Curr Drug Metab; 2016; 17(10):937-970. PubMed ID: 27719626
[TBL] [Abstract][Full Text] [Related]
16. Old Antiprotozoal Drugs: Are They Still Viable Options for Parasitic Infections or New Options for Other Diseases?
Cortez-Maya S; Moreno-Herrera A; Palos I; Rivera G
Curr Med Chem; 2020; 27(32):5403-5428. PubMed ID: 31264538
[TBL] [Abstract][Full Text] [Related]
17. Ribonucleotide reductase as a target to control apicomplexan diseases.
Munro JB; Silva JC
Curr Issues Mol Biol; 2012; 14(1):9-26. PubMed ID: 21791713
[TBL] [Abstract][Full Text] [Related]
18. Targeting polyamines of parasitic protozoa in chemotherapy.
Müller S; Coombs GH; Walter RD
Trends Parasitol; 2001 May; 17(5):242-9. PubMed ID: 11323309
[TBL] [Abstract][Full Text] [Related]
19. The apicoplast as a potential therapeutic target in Toxoplasma and other apicomplexan parasites: some additional thoughts.
Roos DS
Parasitol Today; 1999 Jan; 15(1):41. PubMed ID: 10234180
[No Abstract] [Full Text] [Related]
20. The cell cycle of parasitic protozoa: potential for chemotherapeutic exploitation.
Hammarton TC; Mottram JC; Doerig C
Prog Cell Cycle Res; 2003; 5():91-101. PubMed ID: 14593704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
